New Drug Slashes Heart Attack, Stroke Risk in Diabetics

by VR Sreeraman on  June 29, 2012 at 9:01 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

A new drug may prevent heart attack risk in patients with type 2 diabetes, finds a research.

The revolutionary new treatment could help thousands of patients who do not respond to the commonly used first-line treatment, metformin, the Daily Express reported.
 New Drug Slashes Heart Attack, Stroke Risk in Diabetics
New Drug Slashes Heart Attack, Stroke Risk in Diabetics

Metformin can become ineffective in the long term for many patients, according to an article published online in The Lancet.

Patients are then offered a class of drugs that is known as sulphonylureas in addition.

However, these drugs can lead to low blood sugar levels that is known as hypoglycaemia, and weight gain, putting patients at increased risk of heart attack and stroke.

The new drug, linagliptin, results in significantly less weight gain and also less hypoglycaemia, experts from Tubingen University Hospital, in Germany, has found.

Source: ANI

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Drug Toxicity Clinical Trials - Different Phases of the trial Bellīs Palsy Diabetes - Self-Monitoring of Blood Glucose (SMBG) Diabetes and Exercise Diet Lifestyle and Heart Disease Mitral Valve Stenosis And Mitral Valve Replacement Congenital Heart Disease Signature Drug Toxicity Stress and the Gender Divide 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...